Additionally, the overexpression of IKKβ has been linked to the metastatic progression of hepatocellular carcinoma, through the expression of factors such as receptor activator for NF-κB ligand (RANKL) and osteoprotegerin (OPG) [20]. The gene discussed is IKBKB; the disease is hepatocellular carcinoma.